Patient Guide: A Study to Evaluate the Efficacy and Safety of 2 Doses of EYE103 Compared With Ranibizumab (0.5 mg) in Participants With DME

We'll Help You Connect with This Trial

Quri.ai is a free clinical trial matching service. We help patients like you connect directly with research sites conducting this study.

  • Get matched to the right study location for you
  • Connect directly with study coordinators at 183 participating sites
  • Understand eligibility with our simplified screening tool
  • Free service - we're here to help you access clinical research
Trial ID: NCTNCT06571045
Status: ACTIVE_NOT_RECRUITING
Condition: Diabetic Macular Edema (DME)
Phase: PHASE2, PHASE3

Find a Study Location Near You

This study is available at 183 research sites. We'll help you connect with the location that's right for you.

Participating sites include:
  • Scottsdale, Arizona
  • Fayetteville, Arkansas
  • Springdale, Arkansas
  • • And 180 more locations - let us help you find the closest one

Loading interactive enrollment tools...

The full interactive experience will load momentarily